Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Law channel feed
Heron Therapeutics launches patent suit against Mylan over potential generic for chemo-related nausea
Last year
Pharma
AARP and nonprofits argue Medicare price negotiations are 'imperative' to seniors
Last year
Pharma
Former Alexion VP pleads guilty to insider trading on Portola buyout
Last year
People
DOJ, US Chamber lay out debate over drug price negotiation litigation in Ohio court
Last year
Kenvue, Walgreens and others named in class action lawsuits over efficacy of nasal decongestant
Last year
Pharma
Alexion looks to settle lawsuit over Soliris sales practices for $125M
Last year
Pharma
J&J faces South African competition probe over high tuberculosis drug prices
Last year
Pharma
HHS says Merck's interpretations of IRA 'doom' its legal challenge
Last year
Pharma
FDA+
White House warns over lackluster FDA funding increase in incoming appropriations bill
Last year
FDA+
DOJ and Danco Laboratories petition Supreme Court over mifepristone restrictions
Last year
Pharma
Kroger inks $1.4B settlement deal for opioid lawsuits
Last year
Pharma
New bipartisan House bill includes major PBM reforms
Last year
Pharma
Bristol Myers Squibb and Celgene named in class action suit over cancer blockbuster Pomalyst
Last year
Pharma
iPSC biotech Shoreline Biosciences wins patent infringement suit over Fate, Whitehead Institute
Last year
Pharma
Cell/Gene Tx
Court agrees with AbbVie’s methodology for damages in Takeda case
Last year
Pharma
'FDA is not a physician,' appeals court rules in case against agency's ivermectin messaging
Last year
Pharma
FDA+
Novartis sues over IRA ahead of Entresto price negotiations
Last year
Pharma
Legal experts say some IRA challenges are 'weaker than others'
Last year
Pharma
Alkermes, Teva settle patent suit around opioid-blocker Vivitrol, paving way for generics after three-year fight
Last year
Pharma
Here's how pharma companies might remove their products from price negotiation
Last year
Pfizer challenges Moderna Covid vaccine patents before Patent Trial and Appeal Board
Last year
Pharma
DC appeals court dismisses FTC case against Endo and Impax's opioid agreement
Last year
Alnylam plans to appeal Covid-19 vaccine patent ruling in case against Moderna
Last year
Pharma
FTC pauses challenge of Amgen's $28B Horizon takeover to consider settlement
Last year
Pharma
First page
Previous page
15
16
17
18
19
20
21
Next page
Last page